Immunophenotype of Primary and Engrafted SCID Mouse Cells
Patient No. . | Sample . | Immunophenotype (% positivity) . | ||
---|---|---|---|---|
. | . | CD19 . | CD2 . | CD7 . |
T5 | P | 15 | 99 | 69 |
S | — | 72 | 66 | |
T6 | P | 1 | 99 | 98 |
S | 2 | 96 | 30 | |
T7 | P | 0 | 76 | 97 |
S | 1 | 91 | 38 | |
T9 | P | 803-150 | 90 | 67 |
S | — | 93 | 94 | |
T10 | P | 2 | 45 | 98 |
S | 21 | 59 | 85 | |
T12 | P | — | 79 | 97 |
S | 4 | 24 | 40 | |
T16 | P | 2 | 99 | 94 |
S | 0 | 92 | 81 | |
T18 | P | — | 95 | — |
S | 1 | 89 | 30 | |
C | S | 6 | 15 | 5 |
Patient No. . | Sample . | Immunophenotype (% positivity) . | ||
---|---|---|---|---|
. | . | CD19 . | CD2 . | CD7 . |
T5 | P | 15 | 99 | 69 |
S | — | 72 | 66 | |
T6 | P | 1 | 99 | 98 |
S | 2 | 96 | 30 | |
T7 | P | 0 | 76 | 97 |
S | 1 | 91 | 38 | |
T9 | P | 803-150 | 90 | 67 |
S | — | 93 | 94 | |
T10 | P | 2 | 45 | 98 |
S | 21 | 59 | 85 | |
T12 | P | — | 79 | 97 |
S | 4 | 24 | 40 | |
T16 | P | 2 | 99 | 94 |
S | 0 | 92 | 81 | |
T18 | P | — | 95 | — |
S | 1 | 89 | 30 | |
C | S | 6 | 15 | 5 |
Abbreviations: P, primary patient cells; S, spleen cells (>95% human) from engrafted SCID mouse; C, control (normal SCID spleen cells); −, data not available.
CD19+ T-cell ALL.